At close: December 13 at 1:03:15 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
485,016.00
470,167.00
463,452.00
480,278.00
477,598.00
Cost of Revenue
355,029.00
354,457.00
356,035.00
359,613.00
342,846.00
Gross Profit
129,987.00
115,710.00
107,417.00
120,665.00
134,752.00
Operating Expense
95,857.00
90,634.00
88,796.00
86,408.00
89,308.00
Operating Income
34,130.00
25,076.00
18,621.00
34,257.00
45,444.00
Net Non Operating Interest Income Expense
765.00
442.00
-1,918.00
-2,090.00
-1,756.00
Pretax Income
34,159.00
26,459.00
27,457.00
23,523.00
40,073.00
Tax Provision
3,864.00
5,470.00
2,097.00
4,884.00
8,372.00
Net Income Common Stockholders
30,295.00
20,989.00
25,360.00
18,639.00
31,701.00
Diluted NI Available to Com Stockholders
30,295.00
20,989.00
25,360.00
18,639.00
31,701.00
Basic EPS
1.27
0.88
1.07
0.78
1.33
Diluted EPS
1.27
0.88
1.06
0.78
1.33
Basic Average Shares
23,812.24
23,800.00
23,800.00
23,800.00
23,800.00
Diluted Average Shares
23,885.24
23,873.00
23,873.00
23,891.00
23,922.00
Total Expenses
450,886.00
445,091.00
444,831.00
446,021.00
432,154.00
Net Income from Continuing & Discontinued Operation
30,295.00
20,989.00
25,360.00
18,639.00
31,701.00
Normalized Income
30,693.21
21,112.75
27,767.89
19,590.64
32,717.54
Interest Income
2,838.00
2,577.00
216.00
94.00
536.00
Interest Expense
2,073.00
2,135.00
2,134.00
2,184.00
2,292.00
Net Interest Income
765.00
442.00
-1,918.00
-2,090.00
-1,756.00
EBIT
36,232.00
28,594.00
29,591.00
25,707.00
42,365.00
EBITDA
51,056.00
44,088.00
46,897.00
44,287.00
60,199.00
Reconciled Cost of Revenue
355,029.00
354,457.00
356,035.00
359,613.00
342,846.00
Reconciled Depreciation
14,824.00
15,494.00
17,306.00
18,580.00
17,834.00
Net Income from Continuing Operation Net Minority Interest
30,295.00
20,989.00
25,360.00
18,639.00
31,701.00
Total Unusual Items Excluding Goodwill
-449.00
-156.00
-2,607.00
-1,201.00
-1,285.00
Total Unusual Items
-449.00
-156.00
-2,607.00
-1,201.00
-1,285.00
Normalized EBITDA
51,505.00
44,244.00
49,504.00
45,488.00
61,484.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-50.79
-32.25
-199.11
-249.36
-268.46
12/31/2020 - 11/13/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4198.TWO S&S Healthcare Holding Ltd.
30.70
-0.65%
4745.TWO Cowealth Medical Holding Co., Ltd.
20.30
-1.22%
4161.TWO Bioptik Technology Incorporation
33.30
-1.77%
4188.TWO AmCad BioMed Corporation
21.70
+0.70%
4735.TWO AViTA Corporation
39.55
-2.83%
1781.TWO Health & Life Co., Ltd.
17.15
-3.11%
6747.TWO Brighten Optix Corporation
138.50
+0.36%
4138.TWO Dynamic Medical Technologies Inc.
91.20
-0.87%
4121.TWO Rossmax International Ltd.
16.10
-2.42%
4106.TW Wellell Inc.
24.35
0.00%